Gardasil 9 vaccine now available at Public Health

The Public Health Department is pleased to announce the availability of the Gardasil 9 vaccine for the prevention of certain cancers and diseases caused by the human papillomavirus (HPV).

Gardasil 9 is a vaccine approved by the U.S. Food and Drug Administration (FDA) and recommended by the Centers for Disease Control and Prevention (CDC) for the prevention of HPV-related cancers and diseases. The vaccine is highly effective in protecting against HPV types that cause various cancers such as cervical, vulvar, vaginal, and anal cancers, as well as genital warts.

“Ensuring the health and well-being of our community is our top priority,” said Dr Samuel Williams-Rodriguez, Director Primary Healthcare Services at the HSA. “The availability of Gardasil 9 vaccine at our Public Health Department emphasizes our commitment to providing preventative measures against HPV-related diseases and cancers.”

The Gardasil 9 vaccine is recommended for both males and females, ideally administered between the ages of 9 and 26. However, individuals up to age 45 may benefit from vaccination as well, depending on individual circumstances and discussions with their healthcare provider.

The Public Health Department encourages parents and guardians to speak with their healthcare providers about the importance of HPV vaccination for their children. Additionally, adults within the recommended age range are urged to discuss vaccination with their healthcare provider to determine if Gardasil 9 is right for them.

“We believe in the power of prevention, and the Gardasil 9 vaccine is a significant tool in reducing the burden of HPV-related cancers and diseases in our community,” added Dr. Williams-Rodriguez. “We encourage everyone eligible for vaccination to take advantage of this opportunity to protect themselves and their loved ones.”

For more information about the Gardasil 9 vaccine and vaccination services available at the Public Health Department, please contact 244-2648.